Global Whole Exome Sequencing Market 2023
According to the latest estimates, the global whole exome sequencing market is predicted to be growing at a CAGR of over 14.2% from 2023 to 2029. The top market companies…
Metabolomics is an analytical profiling technique for measuring and comparing large numbers of metabolites present in biological samples. Combining high-throughput analytical chemistry and multivariate data analysis, metabolomics offers a window on metabolic mechanisms. The global metabolomics market market is projected to rise by USD 12 billion by 2028, according to a new report by Gen Consulting Company. It is anticipated to expand at a CAGR of 11.8 percent during the forecast period.
The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global metabolomics market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the metabolomics industry.
This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the product, indication, application, and region. The global market for metabolomics can be segmented by product: assays, bioinformatics, detection techniques, separation techniques. Globally, the separation techniques segment made up the largest share of the metabolomics market. Metabolomics market is further segmented by indication: cancer, cardiovascular disorders, inborn errors of metabolism, neurological disorders, others. The cancer segment captured the largest share of the market in 2021. Based on application, the metabolomics market is segmented into: biomarker discovery, drug discovery, functional genomics, nutrigenomics, toxicology testing, others. According to the research, the biomarker discovery segment had the largest share in the global metabolomics market. On the basis of region, the metabolomics market also can be divided into: Asia Pacific, Europe, North America, MEA (Middle East and Africa), Latin America. North America held the largest revenue share in 2021.
By product:
– assays
– bioinformatics
– detection techniques
– separation techniques
By indication:
– cancer
– cardiovascular disorders
– inborn errors of metabolism
– neurological disorders
– others
By application:
– biomarker discovery
– drug discovery
– functional genomics
– nutrigenomics
– toxicology testing
– others
By region:
– Asia Pacific
– Europe
– North America
– MEA (Middle East and Africa)
– Latin America
The separation techniques market is further segmented into capillary electrophoresis, gas chromatography, liquid chromatography (high-performance liquid chromatography and ultra-performance liquid chromatography). The liquid chromatography (high-performance liquid chromatography and ultra-performance liquid chromatography) segment was the largest contributor to the global metabolomics market in 2021. Furthermore, the detection techniques market has been categorized into mass spectrometry, multivariate analysis, spectroscopy (NMR and FTIR). The mass spectrometry segment is estimated to account for the largest share of the global metabolomics market.
The global metabolomics market report offers detailed information on several market vendors, including Agilent Technologies Inc., Bio-Rad Laboratories Inc., Bruker Corporation, Danaher Corporation, LECO Corporation, Metabolon Inc., Shimadzu Corporation, Thermo Fisher Scientific Inc., Waters Corporation, among others.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
Historical & Forecast Period
This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.
Scope of the Report
– To analyze and forecast the market size of the global metabolomics market.
– To classify and forecast the global metabolomics market based on product, indication, application, region.
– To identify drivers and challenges for the global metabolomics market.
– To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global metabolomics market.
– To identify and analyze the profile of leading players operating in the global metabolomics market.
Why Choose This Report
– Gain a reliable outlook of the global metabolomics market forecasts from 2022 to 2028 across scenarios.
– Identify growth segments for investment.
– Stay ahead of competitors through company profiles and market data.
– The market estimate for ease of analysis across scenarios in Excel format.
– Strategy consulting and research support for three months.
– Print authentication provided for the single-user license.
TABLE OF CONTENTS
FIGURES AND TABLES
PART 1. INTRODUCTION
· Report description
· Objectives of the study
· Market segment
· Years considered for the report
· Currency
· Key target audience
PART 2. METHODOLOGY
PART 3. EXECUTIVE SUMMARY
PART 4. MARKET OVERVIEW
· Introduction
· Drivers
· Restraints
· Impact of COVID-19 pandemic
PART 5. MARKET BREAKDOWN BY PRODUCT
· Assays
· Bioinformatics
· Detection techniques
· Separation techniques
PART 6. MARKET BREAKDOWN BY INDICATION
· Cancer
· Cardiovascular disorders
· Inborn errors of metabolism
· Neurological disorders
· Others
PART 7. MARKET BREAKDOWN BY APPLICATION
· Biomarker discovery
· Drug discovery
· Functional genomics
· Nutrigenomics
· Toxicology testing
· Others
PART 8. MARKET BREAKDOWN BY REGION
· Asia Pacific
· Europe
· North America
· MEA (Middle East and Africa)
· Latin America
PART 9. KEY COMPANIES
· Agilent Technologies Inc.
· Bio-Rad Laboratories Inc.
· Bruker Corporation
· Danaher Corporation
· LECO Corporation
· Metabolon Inc.
· Shimadzu Corporation
· Thermo Fisher Scientific Inc.
· Waters Corporation
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
DISCLAIMER
Agilent Technologies Inc.
Bio-Rad Laboratories Inc.
Bruker Corporation
Danaher Corporation
LECO Corporation
Metabolon Inc.
Shimadzu Corporation
Thermo Fisher Scientific Inc.
Waters Corporation
REPORT ATTRIBUTE | DETAILS |
---|---|
Base Year | 2021 |
Forecast Year | 2022-2028 |
According to the latest estimates, the global whole exome sequencing market is predicted to be growing at a CAGR of over 14.2% from 2023 to 2029. The top market companies…
The global continuous bioprocessing market, in terms of revenue, is expected to grow by 17.9 percent annually through 2029, according to the latest estimates. The top market companies profiles included…
The global virology testing market is projected to expand at a CAGR of ~1.2 percent across the forecast period of 2023 – 2029, according to the latest edition of the…
Please fill out our form and we will get back to you.